학술논문
Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma
Document Type
Article
Author
Source
In: Frontiers in Nuclear Medicine . (Frontiers in Nuclear Medicine, 2022, 2)
Subject
Language
English
ISSN
26738880